Biotage (STO:BIOTA):
Third quarter 2010
· Net sales increased by 21 % to 109.5 MSEK (90.6)
. At comparable exchange rates sales increased by 24 %.
· The operating result amounted to 4.8 MSEK (2.0).
· The result after tax amounted to 4.7 MSEK (1.2).
· Earnings per share amounted to 0.06 SEK (0.01).
· The cash flow from operating activities amounted to 7.0 MSEK (5.0).
· Net cash at September 30, 2010 amounted to 174.9 MSEK (327.2).
· During the quarter 4,299,625 own shares were purchased. At the balance sheet date September 30 Biotage owned a total of 8,741, 612 shares, acquired for 63.6 MSEK, i.e. an average share price of 7.27 SEK.
January - September 2010
· Net sales increased by 6 % to 312.8 MSEK (294.6). At comparable exchange rates net sales increased by 14 %.
· The operating result amounted to 17.1 MSEK (-13.2).
· The result after tax amounted to 14.5 MSEK (-14.6).
· Earnings per share amounted to 0.17 SEK (-0.16).
· The cash flow from operating activities amounted to 45.5 MSEK (17.8).
· MIP Technologies AB was acquired on April 30, 2010.
· The product lines RapidTrace® and TurboVap® and associated assets were acquired on May 25 from Caliper Life Sciences, Inc.
· Dividends to shareholders were paid to the amount of 17.3 MSEK.